Wird geladen...
Clinical trial perspective for adult and juvenile Huntington's disease using genetically-engineered mesenchymal stem cells
Progress to date from our group and others indicate that using genetically-engineered mesenchymal stem cells (MSC) to secrete brain-derived neurotrophic factor (BDNF) supports our plan to submit an Investigational New Drug application to the Food and Drug Administration for the future planned Phase...
Gespeichert in:
| Veröffentlicht in: | Neural Regen Res |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Medknow Publications & Media Pvt Ltd
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4904446/ https://ncbi.nlm.nih.gov/pubmed/27335539 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1673-5374.182682 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|